RCS - Deepverge PLC - Labskin contract

DeepvergeAnnouncement

04/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221004:nRSD5975Ba&default-theme=true

RNS Number : 5975B  Deepverge PLC  04 October 2022

 

4 October 2022

 

DeepVerge PLC

 

("DeepVerge" or "the Company")

 

 

Labskin contract to develop revolutionary new approach to testing for
radiation exposure

 

Collaboration with team of experts to develop new standards to protect
military and civilians working or living near radiation sources

 

Labskin, a DeepVerge (AIM:DVRG) business, announces its selection by the
Intelligence Advanced Research Projects Activity ("IARPA"), part of the US
Office of the Director of National Intelligence, to join a team of experts to
develop new ways to evaluate radiation exposure in civilians and military
personnel.

 

Labskin is a key member of a consortium selected to develop these technologies
in collaboration with a multidisciplinary team of experts including professors
from the University of Columbia in New York, Georgetown University in
Washington DC, the Georgia Institute of Technology, scientists from the
American Type Culture Collection ("ATCC") and computer scientists and
researchers from ARETE Associates, a defence contractor specialising in
sensing solution and machine learning algorithms.

 

In a 3-year project worth $810k to the Company, starting immediately, Labskin
will help develop this technology into minimally invasive testing for
radiation for a programme  known as Targeted Evaluation of
(https://www.iarpa.gov/index.php/research-programs/tei-rex) Ionizing
(https://www.iarpa.gov/index.php/research-programs/tei-rex) Radiation Exposure
("TEI-REX") (https://www.iarpa.gov/index.php/research-programs/tei-rex) .
TEI-REX aims to develop novel approaches to evaluate organisms exposed to
low-dose ionising radiation. Labskin, coupled with Skin Trust Club's expertise
in skin research and microbiology, is essential for the project.

 

The goal of the project is to develop a new biodosimetry standard which could
be applied to maintain the safety of military and civilian populations working
or living in close proximity to ionizing radiation sources, such as: nuclear
plants, nuclear vessels, ammunition, etc. Labskin's contribution is the
creation of a simple non-invasive swab test to collect signatures from the
skin surface that allows machine learning algorithms to detect and quantify
the impact of any amount of radiation exposure on the skin microbiome.

 

David Caballero-Lima, Chief Scientist, Labskin commented:

"This is a unique opportunity to revolutionise the way we test for radiation
exposure.  Labskin and Skin Trust Club are at the forefront of an increasing
number of cutting edge technologies that are changing our world. This
technique can also be applied to detect the impact of pollution or a variety
of chemicals on the environment.  This type of testing could also be used to
detect exposure in complex ecological systems such as the soil, crops or
sediments."

 

Colin O'Sullivan, Chief Information Officer, Labskin commented:

"We are committed to the success of this very exciting project. The inclusion
of artificial intelligence and the opportunity to work with ARETE Associates,
with their vast experience in complex AI applications, will result in further
advances in how AI can be used in conjunction with our skin model at scale.
This project coincides with the expansion of our US labs in Delaware, which
will assist in the implementation of this large project. We believe our proven
ability to transition technology to the field with Skin Trust Club will be
invaluable as we progress this project."

 

 DeepVerge plc                                   Gerard Brandon, CEO         +44 (0) 7340 055 648
 SPARK Advisory Partners Limited                 Neil Baldwin/Andrew Emmott  +44 (0) 113 370 8974

 (Nominated Adviser)
 Turner Pope Investments (TPI) Limited (Broker)  Andy Thacker/James Pope     +44 (0) 20 3657 0050

 

 

About DeepVerge

DeepVerge is an environmental and life science group of companies that
develops and applies AI and IoT technology to analytical instruments for the
analysis and identification of bacteria, viruses and toxins. Utilizing
artificial intelligent data analytics to scientifically prove the impact of
skincare product claims on skin microbiome for most of the top 20 global
cosmetic company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water, rivers,
lakes and reservoirs.

 

Labskin (Life Science Division)

Labskin have been pioneering the development of laboratory grown human skin
platform for more than 15 years and is the only commercially available
lab-grown full thickness human skin model that naturally mimics the skin's
microbiome. With top 20 global consumer health and skincare clients, thousands
of industry tests, the good and bad bacteria that naturally exists on human
skin is present on Labskin when testing skin care, cosmetics, health care,
drug delivery or wound care products. The Labskin test platform and protocols
help clients maintain an optimum real-world environment, when testing their
new ingredients and existing skincare products, that shows the positive or
negative impact on skin's natural microflora.

 

Skin Trust Club

Skin Trust Club (www.skintrustclub.com (http://www.skintrustclub.com) ),
launched in 2021, provides customized skincare routines derived from a home
test kit, lab tested and linked to local environment via a free smartphone App
that updates in real-time and identifies skincare products that suit the
subscribers unique skin microbiome. This revolutionizes how you take care of
your skin with your own skincare routine. The Home Test Kit comprises a single
swab that maps the skin microbiome delivering a report that produces the most
appropriate daily skincare routine based on science, not guesswork. Using
real-time air pollution and weather data from the customer's location, the
Skin Trust App builds a complete picture of the skin microbiome and the impact
of local surroundings.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only /
non-regulatory news releases such as marketing messages, corporate and product
information into the public domain. An RNS Regulatory announcement is required
to be notified under the AIM Rules for Companies.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEADEDEAPAFFA